article thumbnail

TRAINING ARTICLE

Fierce Pharma

THIS IS WHERE THE TEXT OF THE ARTICLE WILL BE. | The introduction that will be displayed in the newsletter.

Training 152
article thumbnail

Article retractions muddy MDMA waters after FDA denial

pharmaphorum

Journal retracts three articles on MDMA-assisted psychotherapy, shortly after FDA blocks approval of @Lykos_PBC's therapy for PTSD

FDA 84
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Purchasing a Scientific Article? 4 Things to Keep in Mind

Copyright Clearance Center

Whether you’re a researcher working on a one-off project, or you’re looking to purchase scientific articles for your organization, here are a few considerations for purchasing STM articles from a document delivery provider.

98
article thumbnail

Cell therapy bigwigs endorse CAR-T in Nature Medicine article amid FDA safety probe

Fierce Pharma

A group of cell therapy experts, including CAR-T pioneers Drs. Bruce Levine and Carl June, wrote in support of continued use of CAR-T therapy.

Safety 314
article thumbnail

Cannes Lions, Ad Forum Spotlight The Chrysalis Initiative & EVERSANA Intouch in New Webinar, Article

Eversana Intouch

Recently, Ad Forum published an article highlighting five campaigns it found to be “ Raising the Bar for Health Equity in Advertising.” And, you can read the Ad Forum article here ! One was our ongoing work with The Chrysalis Initiative, a nonprofit working to eliminate racial disparities in breast cancer treatment.

Pharma 105
article thumbnail

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP

Pharmatutor

ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP. Read more about ARTICLE ON FUTURISTIC APPROACH FOR MEDICAL DIAGNOSTICS ; BIOCHIP Log in or register to post comments About Author. Meenu Maurya. Email : meenudinesh15@gmail.com. Wed, 03/16/2022 - 15:06.

Medical 72
article thumbnail

10 of our most read articles in 2023

PharmaVoice

A presidential candidate, a changing biotech market and an enduring murder mystery — here are PharmaVoice’s most-read articles this year.